NCT03374228View on ClinicalTrials.gov

A Study to Evaluate the Bioavailability of BMS-986205

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 4, 2018

Primary Completion Date

February 16, 2018

Study Completion Date

February 16, 2018

Conditions
Healthy Participants
Interventions
DRUG

BMS-986205

Specified Dose on Specified Days

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY